3 Reasons Why DexCom's Q4 Update Delighted Investors
When you're hot, you're hot. And DexCom (NASDAQ: DXCM) is hot.
The diabetes-focused medical-device stock skyrocketed 83% last year. DexCom got off to a good start in 2020, as well, with a double-digit gain by early February. Investors looking for another catalyst received one when the company announced its fiscal 2019 fourth-quarter and full-year results after the market closed on Thursday.
DexCom's shares jumped around 5% in after-hours trading following the release of its latest results. Here are three reasons why the company's Q4 update delighted investors.
Source Fool.com
